Central sleep apnea with Cheyne-Stokes breathing (Q41276)

From determinar.ia.br - Determine suas informações
Revision as of 07:23, 13 August 2026 by Determinaradmin (talk | contribs) (‎Changed an Item)
Central sleep apnoea with Cheyne-Stokes breathing is characterised by recurrent, predominantly central apnoeas or central hypopneas (more than five per hour) alternating with a respiratory phase exhibiting a crescendo-decrescendo pattern of flow (or tidal volume). The longer cycle length (> 40 seconds) distinguishes central sleep apnoea with Cheyne-Stokes breathing from other central sleep apnoea types. The vast majority of patients with Central sleep apnoea with Cheyne-Stokes breathing have either systolic or diastolic heart failure. Patients with Central sleep apnoea with Cheyne-Stokes breathing have normal or low daytime arterial partial pressure of carbon dioxide (PaCO2). The disturbance is typically associated with atrial fibrillation/flutter, congestive heart failure, or a neurological disorder and is sufficiently severe to cause symptoms such as daytime sleepiness, disturbed sleep, awakening with dyspnoea, or snoring. Note: A definitive diagnosis requires objective evidence based on polysomnography.
Language Label Description Also known as
default for all languages
7A40.3
    English
    Central sleep apnea with Cheyne-Stokes breathing
    Central sleep apnoea with Cheyne-Stokes breathing is characterised by recurrent, predominantly central apnoeas or central hypopneas (more than five per hour) alternating with a respiratory phase exhibiting a crescendo-decrescendo pattern of flow (or tidal volume). The longer cycle length (> 40 seconds) distinguishes central sleep apnoea with Cheyne-Stokes breathing from other central sleep apnoea types. The vast majority of patients with Central sleep apnoea with Cheyne-Stokes breathing have either systolic or diastolic heart failure. Patients with Central sleep apnoea with Cheyne-Stokes breathing have normal or low daytime arterial partial pressure of carbon dioxide (PaCO2). The disturbance is typically associated with atrial fibrillation/flutter, congestive heart failure, or a neurological disorder and is sufficiently severe to cause symptoms such as daytime sleepiness, disturbed sleep, awakening with dyspnoea, or snoring. Note: A definitive diagnosis requires objective evidence based on polysomnography.

      Statements

      CID11:7A40.3
      0 references
      dki-india-7A40.3
      0 references